26 participants
Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2020-09-09
- Start Date:
- 2013-11-30
- Completion:
- 2017-06-15
Conditions
- Pancreatic Cancer
- Stage IV Pancreatic Cancer
Interventions
- DRUG
No Results Yet